Research On Environmental Information Disclosure Of Pharmaceutical Manufacturing Industry

Since the reform and open policy,the rapid development of Chinese economy,industrialization and urbanization process are accelerated,but the rapid growth of economic indicators,the ecological environment is affected by some negative effects.The pharmaceutical industry is an important industry related to people’s livelihood.In recent years,due to the COVID-19 epidemic,the pharmaceutical industry continues to enter the public eye.Due to the demand of fighting the epidemic,the pharmaceutical industry performs relatively well in the sluggish financial market environment.However,as one of the heavily polluting industries,its negative impact on the environment while creating value for the people cannot be ignored.For the rapid and sound economic development of our country,it is indispensable to promote the construction of ecological civilization.Environmental accounting gradually comes into being under the contradiction between ecological environment and economic development.Because of the information asymmetry,the disclosure of environmental accounting information has become a necessary way for external stakeholders to understand the performance of corporate environmental responsibility.At present,a complete disclosure system has not been formed in our country.The pharmaceutical listed companies have many problems in the environmental accounting information disclosure.We need to strengthen the research on the theory and practice of environmental accounting information disclosure to improve the overall disclosure level of the industry.By the method of literature research,case study and comparative analysis,this paper takes Lizon Group environmental accounting information disclosure as the research object,based on information asymmetry theory,sustainable development theory,stakeholder theory and social responsibility theory,on the basis of summing up the scholars’ research results to define related concepts,and to sort out the environmental protection policy of our country.Then choose Chinese pharmaceutical manufacturing listed enterprises as samples,manual collection of their annual report and social responsibility report disclosed environmental accounting information,to understand the industry’s overall disclosure status.Then,according to the principles of timeliness,completeness and comparability,the selection basis of quality evaluation system indicators is clarified,the quality evaluation system of environmental accounting information disclosure is established,and the environmental accounting information disclosed in annual reports and ESG reports of Lizon Group from 2017 to2021 is scored according to the quality evaluation system established above.After a detailed analysis of the four aspects of environmental responsibility information,financial information,performance information and management information,it is found that the disclosure of environmental accounting information of enterprises is not perfect,relatively scattered,difficult to combine qualitative and quantitative information,and lack of voluntary disclosure.The research finds that despite the above problems,Lizon Group has many leading and similar positions in the industry.Worth the industry to learn.According to this paper,it is suggested that pharmaceutical enterprises should issue an independent report to disclose environmental accounting information,and clearly disclose the content;Our accounting theory research should be improved to provide theoretical support for environmental accounting information disclosure;Should continue to advance our country environmental accounting research and strengthen the third party auditing;Enterprises themselves should learn from excellent enterprises and constantly strengthen the awareness of environmental protection.We hope to provide references for Chinese enterprises in the same industry and environmental accounting information disclosure regulation.